6ESB image
Deposition Date 2017-10-20
Release Date 2018-05-02
Last Version Date 2024-05-15
Entry Detail
PDB ID:
6ESB
Keywords:
Title:
BK polyomavirus + 20 mM GT1b oligosaccharide
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.40 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP1
Chain IDs:A (auth: 1), B (auth: 2), C (auth: 3), D (auth: 4), E (auth: 5), F (auth: 6)
Chain Length:361
Number of Molecules:6
Biological Source:BK polyomavirus
Polymer Type:polypeptide(L)
Molecule:Minor capsid protein VP2
Chain IDs:G (auth: 7)
Chain Length:350
Number of Molecules:1
Biological Source:BK polyomavirus
Ligand Molecules
Primary Citation
The Structure of an Infectious Human Polyomavirus and Its Interactions with Cellular Receptors.
Structure 26 839 847.e3 (2018)
PMID: 29706532 DOI: 10.1016/j.str.2018.03.019

Abstact

BK polyomavirus (BKV) causes polyomavirus-associated nephropathy and hemorrhagic cystitis in immunosuppressed patients. These are diseases for which we currently have limited treatment options, but potential therapies could include pre-transplant vaccination with a multivalent BKV vaccine or therapeutics which inhibit capsid assembly or block attachment and entry into target cells. A useful tool in such efforts would be a high-resolution structure of the infectious BKV virion and how this interacts with its full repertoire of cellular receptors. We present the 3.4-Å cryoelectron microscopy structure of native, infectious BKV in complex with the receptor fragment of GT1b ganglioside. We also present structural evidence that BKV can utilize glycosaminoglycans as attachment receptors. This work highlights features that underpin capsid stability and provides a platform for rational design and development of urgently needed pharmacological interventions for BKV-associated diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures